Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
166480
vs
K
KOSPI 200
Over the past 12 months, Corestemchemon Inc has underperformed KOSPI 200, delivering a return of +9% compared to KOSPI 200's +65% growth.
Stocks Performance
166480 vs KOSPI 200
Performance Gap
166480 vs KOSPI 200
Performance By Year
166480 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Corestemchemon Inc
Glance View
Corestemchemon is a South Korean biotech company built around stem-cell and cell-culture technology. It develops and sells regenerative medicine products, related medical materials, and skin-care products that use the company’s laboratory know-how. In simple terms, it turns advanced cell research into products that can be used in hospitals, clinics, and consumer beauty channels. Its customers include medical institutions and distributors that buy its medical products, as well as consumers and retail partners for its cosmetic lines. The company makes money mainly by selling finished products, and it may also earn income from related development work, manufacturing, and product partnerships. That mix gives it both a healthcare side and a consumer side. What makes the business different is that it sits at the intersection of biotech, medicine, and beauty. Instead of being only a drug developer or only a cosmetics brand, it uses the same core cell technology across more than one end market. That can make the company harder to understand than a pure-play manufacturer, but it also gives it multiple ways to bring its research into commercial products.